Perspectives in noninvasive imaging for chronic coronary syndromes.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 10 2022
Historique:
received: 10 05 2022
revised: 05 07 2022
accepted: 21 07 2022
pubmed: 29 7 2022
medline: 30 8 2022
entrez: 28 7 2022
Statut: ppublish

Résumé

Both the latest European guidelines on chronic coronary syndromes and the American guidelines on chest pain have underlined the importance of noninvasive imaging to select patients to be referred to invasive angiography. Nevertheless, although coronary stenosis has long been considered the main determinant of inducible ischemia and symptoms, growing evidence has demonstrated the importance of other underlying mechanisms (e.g., vasospasm, microvascular disease, energetic inefficiency). The search for a pathophysiology-driven treatment of these patients has therefore emerged as an important objective of multimodality imaging, integrating "anatomical" and "functional" information. We here provide an up-to-date guide for the choice and the interpretation of the currently available noninvasive anatomical and/or functional tests, focusing on emerging techniques (e.g., coronary flow velocity reserve, stress-cardiac magnetic resonance, hybrid imaging, functional-coronary computed tomography angiography, etc.), which could provide deeper pathophysiological insights to refine diagnostic and therapeutic pathways in the next future.

Identifiants

pubmed: 35901907
pii: S0167-5273(22)01108-1
doi: 10.1016/j.ijcard.2022.07.038
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-29

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Doralisa Morrone (D)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine-Cardiology Division, University of Pisa, Italy. Electronic address: doralisa.morrone@unipi.it.

Francesco Gentile (F)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine-Cardiology Division, University of Pisa, Italy.

Alberto Aimo (A)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.

Matteo Cameli (M)

Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.

Andrea Barison (A)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Maria Elena Picoi (ME)

Azienda Tutela Salute Sardegna, Ospedale Giovanni Paolo II, Unità di terapia intensiva Cardiologica, Olbia, Sardegna, Italy.

Marco Guglielmo (M)

Department of Cardiovascular Imaging, Centro Cardiologico Monzino, IRCCS, Milan 20138, Italy.

Angelo Villano (A)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Antonio DeVita (A)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Giulia Elena Mandoli (GE)

Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.

Maria Concetta Pastore (MC)

Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.

Francesco Barillà (F)

Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Policlinico Umberto I, Roma, Italy.

Massimo Mancone (M)

Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Policlinico Umberto I, Roma, Italy.

Roberto Pedrinelli (R)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine-Cardiology Division, University of Pisa, Italy.

Ciro Indolfi (C)

Istituto di Cardiologia, Dipartimento di Scienze Mediche e Chirurgiche, Università degli Studi "Magna Graecia", Catanzaro - Mediterranea Cardiocentro, Napoli, Italy.

Pasquale Perrone Filardi (PP)

Department of Advanced Biomedical Sciences, Federico II University of Naples, Italy, Mediterranea Cardiocentro, Naples, Italy.

Saverio Muscoli (S)

U.O.C. Cardiologia, Fondazione Policlinico "Tor Vergata", Roma, Italy.

Isabella Tritto (I)

Università di Perugia, Dipartimento di Medicina, Sezione di Cardiologia e Fisiopatologia Cardiovascolare, Perugia, Italy.

Luca Bergamaschi (L)

Università di Bologna, Alma Mater Studiorum, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Bologna, Italy.

Carmine Pizzi (C)

Università di Bologna, Alma Mater Studiorum, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Bologna, Italy.

Paolo G Camici (PG)

Vita-Salute University and IRCCS San Raffaele Hospital, Milan, Italy.

Mario Marzilli (M)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine-Cardiology Division, University of Pisa, Italy.

Filippo Crea (F)

Department of Cardiovascular Imaging, Centro Cardiologico Monzino, IRCCS, Milan 20138, Italy.

Raffaele De Caterina (R)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine-Cardiology Division, University of Pisa, Italy.

Gianluca Pontone (G)

Department of Cardiovascular Imaging, Centro Cardiologico Monzino, IRCCS, Milan 20138, Italy.

Danilo Neglia (D)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Gaetano A Lanza (GA)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH